Two hundred and thirty-one patients with cerebrovascular disease were examined by spectrophotometry of the cerebrospinal fluid (CSF) and by computer tomography. Many were followed by repeated examinations. Specific diagnoses -bleeding as opposed to non-hemorrhagic or hemorrhagic infarctions -were indicated in 97% by spectrophotometry and in 65% by CT scan in 201 of the 231 cases (excluding 25 patients with transient ischemic attacks and five patients with cerebral tumors with cerebrovascular onset). Comparison between the two methods revealed agreement in most cases, with disagreement in only a few. The specific diagnosis was generally established on only one examination by both methods: repeated examinations were necessary in only a few cases. The results indicated that a combination of the two complementary methods established the diagnosis in almost all cerebrovascular disorders. This was particularly evident if the examinations were performed 24 hours to 21 days after onset of disease. by guest on April 1, 2017 http://stroke.ahajournals.org/ Downloaded from C E Söderström cerebrovascular disease. A comparative study in 231 cases.
SPECIFIC DIAGNOSIS of a particular type of cerebrovascular disease is often difficult to establish by conventional clinical examination. Recently, attempts have been made to achieve better diagnostic methods as a prerequisite for rational therapy.
In intracranial hemorrhage the hemoglobin, depending upon the biochemical environment, is broken down into various visible and non-visible degeneration products. Nonvisible compounds can be found in cases with subdural and intracerebral hematomas and also in those with minimal or previous bleeding from an aneurysm. The appearance of visible and non-visible xanthochromic compounds with different substance patterns can be demonstrated in cerebrospinal fluid (CSF) by spectrophotometry. 1 " 4 "Quantitative" CSF spectrophotometry, with corrections made for traumatic lumbar puncture bleeding 6 and for the influence of serum xanthochromia, 3 ' 4 provides markedly improved diagnosis. High diagnostic accuracy of CSF spectrophotometry has been demonstrated in cerebrovascular diseases, 6 and in subacute and chronic subdural hematomas. 7 Computer tomography (CT scan) also has a recognized diagnostic value in cerebrovascular lesions. With it not only is it possible to differentiate between cerebral infarctions and bleeding but also to determine the exact localization and extent of a lesion. 8 " 11 The changes seen on the CT scan are direct and indirect. The direct changes in cerebral infarction are characterized by decreased X-ray attenuation and in hemorrhage by increased X-ray attenuation when compared to normal brain tissue, at least during the first weeks after onset. Occasionally there is decreased as well as increased attenuation within the same region, which has been interpreted as a sign of hemorrhagic infarction. The indirect changes -distortion of anatomical structures normally seen on the CT scan -are most pronounced in extra-and intracerebral hematomas.
In previous studies of cerebrovascular diseases, specific diagnoses -bleeding as opposed to non-hemorrhagic or hemorrhagic infarctions -were possible by spectrophotometry of CSF in about 95% of the cases and by CT scan in about 75% of the cases. 12 " The results suggested that a combination of the two methods might insure a specific diagnosis in almost all patients with cerebrovascular disorders, particularly if the examinations were performed during the first weeks after the onset of disease. Earlier reports were based on only 50 to 80 cases.
Methods
During the past three years approximately 500 patients, with confirmed or probable cerebrovascular disorders admitted to the Karolinska Hospital, were examined by CT scan. The present material was collected during the first twoand-a-half years and encompasses 231 patients whose spinal fluid (CSF) was also examined by spectrophotometry. The patients were selected to include as many cases as possible with verified or a clinically highly probable diagnosis of thromboembolic or hemorrhagic lesions. However, in 57 of the 231 patients examined clinically the exact nature of the cerebrovascular lesion could not be determined (table 1) .
Spectrophotometry of CSF was carried out as described by Kjellin, 3 ' 4 with a Beckman DB-GT spectrophotometer. The spectrophotometric patterns (table 2) are illustrated by the spectrophotograms (figs. 1 and 2). In the present study the bleeding and infarction patterns were not further subdivided.
The CT scans were done on an EMI-scanner. One hundred sixty-one cases were examined by an 80 X 80 matrix, and 70 patients were examined by a 160 X 160 matrix.
In 26 cases repeat examinations were performed following intravenous injection of contrast medium (Isopaque cerebral), 1 ml/kg body weight. Typical images obtained by CT scan in infarction and bleeding as compared to normal findings are illustrated in figure 3 .
Four hundred and one tomographic and 405 spectrophotometric examinations were carried out in this series of 231 patients. Many patients were repeatedly examined by CT scan and spectrophotometry, some up to 8 times; 1-3 times during the first week and then once a week or at longer intervals. Some patients were followed for more than one year. The first examinations were performed in about twothirds of the patients during the first two weeks, and in about one-fourth of the patients during the first three days after onset of disease. To obtain a proper comparison between spectrophotometry and CT scan, both examinations were performed as closely together as possible. Thus, the lumbar puncture was generally carried out within 24 hours after the CT scan. In a minority of patients the two examinations could not be performed together mainly because of the condition of the patient or of technical delay. No secondary effects of lumbar puncture were observed in any of the patients.
As shown in previous investigations, there may be a delay of several hours after acute hematomas before spectrophotometry gives definite diagnostic information. Therefore, repeated examinations were performed in all patients where spectrophotometry did not show a clear bleeding pattern during the first 24 hours. Repeated studies were also performed by CT scan in patients where the initial examination performed during the first 24 hours after onset gave nonconclusive information. The results of CSF spectrophotometry and CT scan were checked separately by investigators without knowledge of the clinical findings. After independent evaluation of these studies, correlations were made.
Cerebral angiography of clinically relevant vessels was performed in 106 patients. Isotope encephalography was performed in 117 patients using a gamma camera mainly to obtain a topographic diagnosis. The examinations in several patients were performed with some time lapse between the CT scan and spectrophotometry. Table 1 shows the results of CSF spectrophotometry and CT scan in 64 patients with the diagnosis of cerebrovascular disease verified by angiography, operation or autopsy; and in 9 patients with a diagnosis of subarachnoid hemorrhage and the lateral medullary syndrome of Wallenberg made strictly by clinical findings. Spectrophotometry showed a bleeding pattern in all patients with hemorrhage and an infarction pattern in all but 4 patients with infarction. Xanthochromia of the spinal fluid was clearly visible in only FIGURE 1 . CSF spectropholometric patterns found in healthy subjects (I) and in patients with intracranial bleeding (2) (3) (4) (5) . During the first week after onset of bleeding the pattern shown in curve 4 is frequently found with cerebral contusions, but may also be seen in non-traumatic cerebral hematomas. No scale expansion used. Wavelength in nm on the abscissa. 50 percent of the 32 patients with verified bleeding (table 3) . A spectrophotometric bleeding pattern was found in 2 patients with infarction, but autopsy in these revealed a strong hemorrhage in the infarcted area.
Results
CT scan showed increased X-ray attenuation in about two thirds of the patients with hemorrhage and decreased X-ray attenuation in about the same percentage with infarction. In the remaining patients in both groups, CT scan gave nonconclusive diagnostic information.
Twenty-five patients had transient ischemic attacks. This diagnosis was restricted to patients whose symptoms and clinical signs disappeared within 24 hours. Twenty-three had non-hemorrhagic CSF spectrophotometry and two were difficult to evaluate. In the 23 patients the spectrophotometric aberrations were mostly slight as compared with the findings in ischemic infarctions. Only one case had decreased X-ray attenuation in CT scan.
In the 71 patients with a highly probable clinical diagnosis of cerebrovascular disease the findings on spectrophotometry and CT scan were usually in good agreement. In the 57 patients with cerebrovascular disorders without specific diagnoses spectrophotometric and tomographic results were in agreement in most instances ( results in one and CT scan results in two cases. Hemorrhagic infarction was indicated more often by spectrophotometry than by the CT scan.
The diagnostic accuracy of the CT scan was particularly low in certain groups of patients. In only 5 of 13 patients with subarachnoid hemorrhage did the CT scan indicate bleeding. In one of these, bleeding was limited to the subarachnoid space and in four patients an intracerebral hematoma with certain or probable bleeding into the ventricular system was found.
The CT scan gave positive diagnostic information in only three of the 16 cases with infratentorial infarctions. Autopsy in two of the patients with no evident abnormality on CT scan revealed large infarctions. In 10 of 17 patients with verified or clinically highly probable supratentorial cerebral infarctions with minimal clinical symptoms at onset no abnormality was visualized on CT scan. In one-third of the instances where the CT scan gave inconclusive diagnostic information, the CT scan was first done more than 21 days after the onset of disease. In contrast, only 17 percent of the group where specific diagnoses were obtained had CT scans performed this long after the onset of symptoms. Studies of the results of computer tomography and spectrophotometry related to time of onset were made. During the first 24 hours after onset 45 of 231 patients were examined by spectrophotometry and 27 by CT scan. In 13 of the 17 cases with hemorrhage, when spectrophotometry was performed during the first 24 hours after onset, a bleeding pattern was detected on the first examination ( fig. 4 ). In the remaining four patients the first spectrophotometric examination showed a non-hemorrhagic pattern in two and a slight hemorrhagic component consistent with a hemorrhagic infarction in the others. Repeated examinations, however, revealed bleeding in all four. In all but two patients with intracranial hemorrhage, spectro photometric examinations performed during day 2 to 14 showed a bleeding pattern. In the two patients with spectropho to metric patterns not diagnostic of bleeding the first spectrophotometric examinations were performed two and three days respectively after onset and showed changes consistent with a hemorrhagic infarction. On repeated examinations a few days later a typical bleeding pattern was found.
Spectro photometric examinations performed later than 21 days after onset were less diagnostically accurate. However, in some instances of intracerebral and subdural hematoma the bleeding pattern may persist for many weeks.
Among the 27 CT scans performed during the first 24 hours after onset of symptoms, 11 showed hemorrhage and 10 infarction. Six of the patients with hemorrhage were examined one to two hours after onset, and three of the patients where CT scan indicated infarction had the examination eight to 12 hours after onset. In six patients the CT scan gave inconclusive information initially and on repeated studies. Changes in tissue X-ray attenuation and in the distortion of the normal anatomy occurring between repeated CT scans have been described previously." Such changes, which occur with increasing age of the vascular lesions, were found also in the present study. With small in- farction, a complete return to a normal scan can be observed, while large infarctions were seen to persist. For intracerebral hemorrhage the X-ray attenuation changed from a well-defined area with increased attenuation to an illdefined area with decreased attenuation i.e. resembling an infarction, or even appearing normal. In the present study, in some patients the signs of hemorrhage disappeared within three weeks. Generally, however, the disappearance takes place over a longer period of time -4 to 10 weeks.
In five patients with a sudden onset of symptoms clinically resembling a vascular accident, a cerebral tumor was later verified by operation or autopsy. Four were gliomas and one had multiple cerebral metastases from a pulmonary carcinoma. The CT scan and spectrophotometry indicated bleeding in two and three of these five patients respectively (table 1) . Cerebral tumor was initially suspected on CT scan in two patients and repeated studies established the diagnosis in the other three.
Examination by CT scan before and after intravenous injection of Isopaque cerebral was performed in 26 patients. In one patient there was a detectable local increase in X-ray attenuation and a questionable increase in two further cases.
Discussion
The results of these studies established the high diagnostic reliability of CSF spectrophotometry in the differential diagnosis of bleeding and infarction in cerebrovascular diseases. The findings also show that CT scan is valuable in the specific diagnosis of supratentorial cerebrovascular lesions and also in the detection of infratentorial hematomas. A comparison between the two methods in the present study reveals good agreement, with contradictory results obtained in only a few cases. However, spectrophotometry gives helpful diagnostic information in almost all patients while the CT scan indicates a specific diagnosis in only two-thirds.
Spectrophotometry is not helpful in the localization or determination of the size of a lesion. In patients with acute hematomas there may be a delay of several hours or even some days before spectrophotometry gives diagnostic information.
The non-hemorrhagic infarction pattern in spectrophotometry is not a specific entity but it can give helpful diagnostic information for the group of cerebrovascular diseases. It is often difficult to distinguish between the spectro-photometric findings in non-hemorrhagic infarctions and the patterns observed in nonvascular neurological disorders with blood brain barrier damage. Patterns consistent with hemorrhagic infarction may be found initially or at a late stage with a cerebral hemorrhage. On the other hand, hemorrhagic infarctions with a large hemorrhagic component may look like bleeding on spectrophotometry.
The CT scan will demonstrate intracerebral hematomas immediately after onset. It may also detect infarctions as early as 8 hours after onset. However, in some patients no evident abnormality can be found up to 2-3 days after onset.
Hemorrhages near skeletal structures and extracerebral bleedings, such as subdural hematomas and subarachnoid hemorrhages as well as hemorrhagic infarctions, are more difficult to detect on CT scan than by spectrophotometry. The CT scan often shows no evident abnormality in small infarctions and infratentorial ischemic lesions. The use of a 160 X 160 matrix as well as special studies of the infra-No of examinations 31H 20- VOL 8, No 5, SEPTEMBER-OCTOBER 1977 tentorial region may increase the diagnostic accuracy in such lesions.
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Spectrophotometry cannot differentiate vascular accidents in normal brain tissue from those in tumor tissue. It can also be difficult, at least initially, to differentiate on CT scan between cerebrovascular disease and cerebral tumor with or without vascular incidents. Gliomas with low attenuation values may have the same appearance on the CT scan as infarction. Only repeated examinations by CT scan of an intracerebral hematoma may reveal a cerebral tumor complicated by a bleeding. A possible source of error in the diagnosis of cerebrovascular disease is cerebral tumor with an abrupt "cerebrovascular"-like onset. CT examinations after the administration of intravenous X-ray contrast medium have been suggested as being helpful in differentiating vascular lesions from cerebral tumors in doubtful cases. 15 In the present study only one of 26 cases, a clinically highly probable infarction, showed a definite perifocal increase in X-ray attenuation following injection of the contrast medium. Yock and Marshall have reported marked contrast enhancement in four of twenty patients with infarctions. 16 In most infarctions in our patients the attenuation changes may have been too small for visual detection.
This study suggests that a combination of the two methods, spectrophotometry and CT scan, can make a specific diagnosis possible in almost all patients with cerebrovascular disorders. This is particularly true if the examinations are performed between 24 hours and 21 days after the onset of symptoms. With increasing time after hemorrhage, infarction patterns may be shown on spectrophotometry; on CT scan an intracerebral hemorrhage may change and appear as an infarction. Both spectrophotometry and CT scan may reveal a hemorrhage in instances of subdural and intracerebral hematomas many weeks after onset. Repeated examinations of spectrophotometry and CT scan are recommended in clinically doubtful cases with initial nonconclusive diagnostic findings.
Spectrophotometry of CSF is a simple diagnostic method which will identify bleedings or bleeding components of in-farctions which is often the crucial question in deciding about early and active therapy. However, the combination of the two diagnostic methods, spectrophotometry and CT scan, offer the greatest possibility for improved diagnosis and better management of patients with cerebrovascular disease.
